Anti-AGL Antibody, Rabbit Monoclonal

<strong>Anti-AGL Antibody, Rabbit Monoclonal</strong>_x000D_ <strong>Catalog number:</strong> B2018510_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 50 µL_x000D_ <strong>Molecular Weight or Concentration:</strong> 175¬†kDa_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20¬∞C_x000D_ <strong>Keywords:</strong> AGL, GDE, glycogen debranching enzyme_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MŒ©-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Massari F, Ciccarese C, Santoni M, Iacovelli R, Mazzucchelli R, Piva F, Scarpelli M, Berardi R, Tortora G, Lopez-Beltran A, Cheng L, Montironi R. Metabolic phenotype of bladder cancer Cancer Treat Rev. 2016 Apr;45:46-57._x000D_ 2: Richmond CS, Oldenburg D, Dancik G, Meier DR, Weinhaus B, Theodorescu D, Guin S. Glycogen debranching enzyme (AGL) is a novel regulator of non-small cell lung cancer growth Oncotarget. 2018 Mar 30;9(24):16718-16730._x000D_ 3: Weinhaus B, Guin S. Involvement of glycogen debranching enzyme in bladder cancer Biomed Rep. 2017 Jun;6(6):595-598._x000D_ 4: Guin S, Ru Y, Agarwal N, Lew CR, Owens C, Comi GP, Theodorescu D. Loss of Glycogen Debranching Enzyme AGL Drives Bladder Tumor Growth via Induction of Hyaluronic Acid Synthesis Clin Cancer Res. 2016 Mar 1;22(5):1274-83._x000D_ 5: Sun L, Wang L, Jiang M, Huang J, Lin H. Glycogen debranching enzyme 6 (AGL), enolase 1 (ENOSF1), ectonucleotide pyrophosphatase 2 (ENPP2_1), glutathione S-transferase 3 (GSTM3_3) and mannosidase (MAN2B2) metabolism computational network analysis between chimpanzee and human left cerebrum Cell Biochem Biophys. 2011 Dec;61(3):493-505._x000D_ 6: Bao Y, Dawson TL Jr, Chen YT. Human glycogen debranching enzyme gene (AGL): complete structural organization and characterization of the 5' flanking region Genomics. 1996 Dec 1;38(2):155-65._x000D_ 7: Herszberg B, Mata X, Giulotto E, Decaunes P, Piras FM, Chowdhary BP, Chaffaux S, Gu√©rin G. Characterization of the equine glycogen debranching enzyme gene (AGL): Genomic and cDNA structure, localization, polymorphism and expression Gene. 2007 Dec 1;404(1-2):1-9._x000D_ 8: Tarnopolsky MA. Myopathies Related to Glycogen Metabolism Disorders Neurotherapeutics. 2018 Oct;15(4):915-927._x000D_ 9: Pagliarani S, Lucchiari S, Ulzi G, Violano R, Ripolone M, Bordoni A, Nizzardo M, Gatti S, Corti S, Moggio M, Bresolin N, Comi GP. Glycogen storage disease type III: A novel Agl knockout mouse model Biochim Biophys Acta. 2014 Nov;1842(11):2318-28._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/20301788">10: Schreuder AB, Rossi A, Gr√ºnert SC, Derks TGJ. Glycogen Storage Disease Type III 2010 Mar 9 [updated 2022 Jan 6]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews(¬Æ) [Internet]. Seattle (WA): University of Washington, Seattle; 1993‚Äì2024.</a>_x000D_ _x000D_ <strong>Products Related to Anti-AGL Antibody, Rabbit Monoclonal can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>